Response to Barbieri, "Response to Veenstra et al's 'benzoyl peroxide use in acne therapy: Evaluating the association with acute myeloid leukemia risk'"

J Am Acad Dermatol. 2024 Oct;91(4):e111-e112. doi: 10.1016/j.jaad.2024.06.036. Epub 2024 Jun 19.

Authors

Jesse Veenstra¹, David Ozog²

Affiliations

¹ Department of Dermatology, Henry Ford Health, Detroit, Michigan; Department of Medicine, Michigan State University, East Lansing, Michigan. Electronic address: [email protected].
² Department of Dermatology, Henry Ford Health, Detroit, Michigan; Department of Medicine, Michigan State University, East Lansing, Michigan.

PMID: 38906263
DOI: 10.1016/j.jaad.2024.06.036

No abstract available

Keywords: acne; acute myeloid leukemia; benzene; benzoyl peroxide; epidemiology; malignancy; risk.

Publication types

Letter
Comment

MeSH terms

Acne Vulgaris* / drug therapy
Benzoyl Peroxide* / adverse effects
Benzoyl Peroxide* / therapeutic use
Dermatologic Agents / adverse effects
Dermatologic Agents / therapeutic use
Humans
Leukemia, Myeloid, Acute* / chemically induced
Leukemia, Myeloid, Acute* / drug therapy

Substances

Benzoyl Peroxide
Dermatologic Agents